“YEZTUGO (lenacapavir) is a new injectable form of long-acting PrEP that only requires 2 doses per year to prevent HIV infection, and 3 million people are expected to get access to the drug by 2028 via The Global Fund. Sounds great, right? (1/5)”
- #social
- #bluesky
- #self-published